Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALOGLIPTIN Cause Disseminated intravascular coagulation? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disseminated intravascular coagulation have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 0.4% of all adverse event reports for ALOGLIPTIN.

6
Reports of Disseminated intravascular coagulation with ALOGLIPTIN
0.4%
of all ALOGLIPTIN reports
5
Deaths
6
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From ALOGLIPTIN?

Of the 6 reports, 5 (83.3%) resulted in death, 6 (100.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does ALOGLIPTIN Cause?

Pemphigoid (98) Pancreatitis (66) Diarrhoea (60) Nausea (60) Rash (55) Hypoglycaemia (46) Vomiting (44) Pancreatitis acute (43) Drug ineffective (42) Pruritus (42)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which ALOGLIPTIN Alternatives Have Lower Disseminated intravascular coagulation Risk?

ALOGLIPTIN vs ALOGLIPTIN\METFORMIN ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE ALOGLIPTIN vs ALOSETRON ALOGLIPTIN vs ALPELISIB ALOGLIPTIN vs ALPHA.-LIPOIC ACID

Related Pages

ALOGLIPTIN Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation ALOGLIPTIN Demographics